Jazz Pharma to purchase GW Pharma for $7.2 billion; plans to aid cannabis-based drug to portfolio
Jazz Pharmaceuticals said on Wednesday it had consented to purchase GW Pharmaceuticals in a $7.2 billion money and-stock arrangement which
Read moreJazz Pharmaceuticals said on Wednesday it had consented to purchase GW Pharmaceuticals in a $7.2 billion money and-stock arrangement which
Read more